| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42cc50551658c2a29a8fd2ec7d9bc03e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0874d88fd0f795c18c9e90b6e2c8d987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6175ba1eb2723f950bbce7c4fa375b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaa3fc65a98d1f9deaebf503e52bc8f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a7f9376f358395ff72cedde6500229 |
| publicationDate |
2021-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021030335-A1 |
| titleOfInvention |
A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof |
| abstract |
A stereoisomerically pure NK-3 receptor antagonist is provided, including crystalline free base and salt forms thereof, as well as pharmaceutical compositions comprising the same. Also provided are methods for production of the stereoisomerically pure NK-3 receptor antagonist, as well as its use in the context of treating conditions for which antagonism of the NK-3 receptor is desired. |
| priorityDate |
2019-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |